Abraxis seeks advice on strategic options, sources say

04/14/2010 | Reuters

Abraxis BioScience reportedly hired Goldman Sachs and Lazard to help it decide whether to put itself up for sale. Shares of the company have been increasing since results of a late-stage trial for Abraxane were released showing that the treatment significantly improved the overall response rate of patients with advanced nonsmall-cell lung cancer.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Compliance Specialist
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC
Regulatory Senior Managing/Principal Engineer/Scientist
Menlo Park, CA
Director of Claims
Meridian Health Plan
Detroit, MI